These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15585308)

  • 21. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
    Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
    AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gammadeltaT cell-mediated regulation of chemokine producing macrophages during Listeria monocytogenes infection-induced inflammation.
    Tramonti D; Rhodes K; Martin N; Dalton JE; Andrew E; Carding SR
    J Pathol; 2008 Oct; 216(2):262-70. PubMed ID: 18767021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
    AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities.
    Ji C; Brandt M; Dioszegi M; Jekle A; Schwoerer S; Challand S; Zhang J; Chen Y; Zautke L; Achhammer G; Baehner M; Kroetz S; Heilek-Snyder G; Schumacher R; Cammack N; Sankuratri S
    Antiviral Res; 2007 May; 74(2):125-37. PubMed ID: 17166600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
    Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
    Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies.
    Zhang J; Rao E; Dioszegi M; Kondru R; DeRosier A; Chan E; Schwoerer S; Cammack N; Brandt M; Sankuratri S; Ji C
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1386-97. PubMed ID: 17242138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
    J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
    Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
    J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction, purification, and immunogenicity of recombinant cystein-cystein type chemokine receptor 5 vaccine.
    Wu K; Xue X; Wang Z; Yan Z; Shi J; Han W; Zhang Y
    Protein Expr Purif; 2006 Sep; 49(1):108-13. PubMed ID: 16600624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients.
    Lalezari J; Yadavalli GK; Para M; Richmond G; Dejesus E; Brown SJ; Cai W; Chen C; Zhong J; Novello LA; Lederman MM; Subramanian GM
    J Infect Dis; 2008 Mar; 197(5):721-7. PubMed ID: 18266604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
    Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
    J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of soluble CD4 with the chemokine receptor CCR5.
    Wang X; Staudinger R
    Biochem Biophys Res Commun; 2003 Aug; 307(4):1066-9. PubMed ID: 12878220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.
    Atemezem A; Mbemba E; Vassy R; Slimani H; Saffar L; Gattegno L
    Biochem J; 2001 May; 356(Pt 1):121-8. PubMed ID: 11336643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.